Smith Andrew Alasdair
SEC-identified person · CIK 1309614 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Medicus Pharma Ltd. MDCX | Chief Operating Officer | filed 2025–2026 |
| First Trust/Abrdn Global Opportunity Income Fund FAM | Officer | filed 2017–2017 |
| First Trust/Abrdn Emerging Opportunity Fund FEO | Officer | filed 2006–2017 |
| Aberdeen Global Diversified Fixed Income Fund, Inc. ADG | Officer | filed 2013–2013 |
| Abrdn Australia Equity Fund, INC. IAF | Vice President - Compliance | filed 2007–2007 |
| Abrdn Asia-Pacific Income Fund, INC. FAX | Vice President - Compliance | filed 2007–2007 |
| Abrdn Global Income Fund, INC. [FCO] | Vice President - Compliance | filed 2007–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.